Before you sell to, join or invest in Autoimmunity Biologic Solutions Inc.
MentionFox check on Autoimmunity Biologic Solutions Inc.: only 2 sources on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/autoimmunity-biologic-solutions-inc-form-d-24000001
Check Autoimmunity Biologic Solutions Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Autoimmunity Biologic Solutions Inc.?
Autoimmunity Biologic Solutions Inc. filed an amended Form D with the Securities and Exchange Commission on 2024-11-22.
Autoimmunity Biologic Solutions Inc. filed an amended Form D notice of an exempt securities offering with the SEC on November 22, 2024. The filing reports $3.21M sold. Its industry group is Biotechnology. It names Gaddiel Galarza-Munoz (Executive Officer), Eugene Williams (Executive Officer, Director), Brock Reeve (Director) (SEC Form D/A, November 22, 2024).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Run the free check on Autoimmunity Biologic Solutions Inc. →
Sell to companies like Autoimmunity Biologic Solutions Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-11-22 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Autoimmunity Biologic Solutions Inc.
Free to see. No signup.
Get an email when Autoimmunity Biologic Solutions Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Autoimmunity Biologic Solutions Inc. raises, hires or launches. No email unless you switch it on.
Watch Autoimmunity Biologic Solutions Inc. →Get the full cited report on Autoimmunity Biologic Solutions Inc.
What the filing shows about Autoimmunity Biologic Solutions Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Autoimmunity Biologic Solutions Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Autoimmunity Biologic Solutions Inc.'s address as 2710 Reed Rd, Suite 160, Houston, TX 77051.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Autoimmunity Biologic Solutions Inc. →
Amended on 2026-05-06: the offering size changed from $2,210,242 to $3,209,233; the amount sold changed from $2,210,242 to $3,209,233; the number of investors changed from 12 to 15. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Autoimmunity Biologic Solutions Inc. See pricing
Autoimmunity Biologic Solutions Inc. is a registered filer with the SEC (CIK 2045812) and has filed since 2024-11-22. 2 filings are on record, the latest on 2026-05-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Autoimmunity Biologic Solutions Inc.'s Form D of 2024-11-22 names Gaddiel Galarza-Munoz, Eugene Williams, Brock Reeve and 2 more as its officers, directors or promoters.
Its new offerings report $2.21M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
Gaddiel Galarza-Munoz is named as Executive Officer on the Form D that Autoimmunity Biologic Solutions Inc. filed with the SEC on 22 November 2024, one of 5 people that filing names.
Eugene Williams is named as Executive Officer and Director on the Form D that Autoimmunity Biologic Solutions Inc. filed with the SEC on 22 November 2024, one of 5 people that filing names.
Brock Reeve is named as Director on the Form D that Autoimmunity Biologic Solutions Inc. filed with the SEC on 22 November 2024, one of 5 people that filing names.
Jimmy Lu is named as Director on the Form D that Autoimmunity Biologic Solutions Inc. filed with the SEC on 22 November 2024, one of 5 people that filing names.
Mariano Garcia-Blanco is named as Director on the Form D that Autoimmunity Biologic Solutions Inc. filed with the SEC on 22 November 2024, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2024-11-22 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Autoimmunity Biologic Solutions Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Autoimmunity Biologic Solutions Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Autoimmunity Biologic Solutions Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Autoimmunity Biologic Solutions Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Autoimmunity Biologic Solutions Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Autoimmunity Biologic Solutions Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Houston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/autoimmunity-biologic-solutions-inc-form-d-24000001